Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026)

Valneva SE (VALN) posted Other Accumulated Expenses of $6.3 million for Q1 2026, down 4.34% sequentially from $6.6 million in Q4 2025, and up 33.21% YoY from $4.8 million in Q1 2025.

Analysis

Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

Valneva SE has reported Other Accumulated Expenses for 4 years, with the latest figure at $6.3 million in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 33.21% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (up 33.21% YoY) and the FY2025 annual result came in at $6.6 million, up 18.76% from the prior year.
  • Other Accumulated Expenses slipped to $6.3 million in Q1 2026 per VALN's latest filing, from $6.6 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $10.8 million in Q2 2025 and troughed at $636956.4 in Q4 2023.
  • A 4-year average of $6.2 million and a median of $6.3 million in 2026 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses jumped 764.33% in 2024, then increased 20.29% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $636956.4 in 2023, then soared by 764.33% to $5.5 million in 2024, then climbed by 20.29% to $6.6 million in 2025, then fell by 4.34% to $6.3 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $6.3 million, $6.6 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.38 Mn
Mar 31, 2026 6.33 Mn
Dec 31, 2025 6.62 Mn
Sep 30, 2025 8.80 Mn
Jun 30, 2025 10.79 Mn
Mar 31, 2025 4.76 Mn
Dec 31, 2024 5.51 Mn
Dec 31, 2023 636,956.43